CLE: cutaneous lupus erythematosus HZ: herpes zoster SLE: systemic lupus erythematosus TLE: tumid lupus erythematosus VZV: varicella zoster virus INTRODUCTION Topical corticosteroids are commonly used in the treatment of a wide range of skin manifestations of systemic lupus erythematosus (SLE). Patients with SLE are also known to have an increased risk of herpes zoster (HZ). Here we present a r...

OBJECTIVE The goal of the present study was to estimate the risk ratio of herpes zoster among systemic lupus erythematosus patients after disease onset compared with a cohort of patients without systemic lupus erythematosus over a three-year period. METHODS A nationwide population-based cohort study using the National Health Insurance Research Database identified 10,337 new cases of systemic ...

References DINES, D.E., CLAGETT, O.T. & GOOD, C.A. (1967) Nontuberculous pulmonary parenchymal conditions predisposing to spontaneous pneumothorax. Journal of Thoracic and Cardiovascular Surgery, 53, 726. DUBOIs, E.L. (1966) Lupus Erythematosus, p. 172. McGrawHill Book Company Inc., New York Blakiston Division. HOFFBRAND, B.l. & BECK, E.R. (1965) 'Unexplained' dyspnoea and shrinking lungs in sy...

Pleural involvement in drug-induced lupus erythematosus is not uncommon. Lupus erythematosus cells were found in vivo in the pleural of an elderly patient who had received procainamide (Pronestyl) hydrochloride (2 gm daily) for nine months. Patients who initially have pleural effusions while receiving drugs capable of inducing lupus erythematosus should have the fluid analyzed for lupus erythem...

AMA Knosala E, Wąsik G. Toxic epidermal necrolysis in a patient with lupus erythematosus. Dermatology Review/Przegląd Dermatologiczny. 2023;110(2):176-179. doi:10.5114/dr.2023.127830. APA Knosala, E., & Wąsik, (2023). Dermatologiczny, 110(2), 176-179. https://doi.org/10.5114/dr.2023.127830 Chicago Emilia, and Grażyna Wąsik. 2023. "Toxic erythematosus". Dermatologiczny 110 (2): Harvard pp.176-17...

AMA Staniszewska I, Kalińska-Bienias A. Inverse psoriasis in a patient with history of subacute cutaneous lupus erythematosus. Dermatology Review/Przegląd Dermatologiczny. 2023;110(1):56-64. doi:10.5114/dr.2023.127664. APA Staniszewska, I., & Kalińska-Bienias, (2023). Dermatologiczny, 110(1), 56-64. https://doi.org/10.5114/dr.2023.127664 Chicago Izabela, and Agnieszka Kalińska-Bienias. 2023. "I...

background: systemic lupus erythematosus is a kind of multi-system autoimmune disorder with unknown aetiology and it produces antibodies against various tissues. case presentation:the patient wasa 44-year-old woman with a history of systemic lupus erythematosus for approximately five years, along with underlying diseases including peptic ulcers, asthma, hypertension and diabetes in the past 10 ...

OBJECTIVES To determine the serum interleukin-17 (IL-17) levels in childhood-onset systemic lupus erythematosus patients and to evaluate the association between IL-17 and clinical manifestations, disease activity, laboratory findings and treatment. METHODS We included 67 consecutive childhood-onset systemic lupus erythematosus patients [61 women; median age 18 years (range 11-31)], 55 first-d...

Two children with lupus erythematosus and myelopathy were studied. The first child developed the neonatal lupus erythematosus syndrome associated with transplacentally acquired anti-Ro/SSA antibodies. The cutaneous manifestations of neonatal lupus erythematosus disappeared but a residual myelopathy was confirmed at 16 months of age. The second child developed cutaneous lupus erythematosus at 3 ...

Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...